SCHEMBL6663012

SCHEMBL6663012

O=C(N1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)[C@@]1(Cc2ccccc2)CCCCN1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.55
CACNA2D1 P54289 1/20 0.50
CACNA1B Q00975 1/20 0.50
CACNB1 Q02641 1/20 0.50
CACNA1C Q13936 1/20 0.50
PARP1 P09874 4/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
ATM Q13315 1/20 0.45
OPRM1 P35372 3/20 0.43
OPRD1 P41143 3/20 0.43
OPRK1 P41145 3/20 0.43
OPRL1 P41146 3/20 0.43
DPP8 Q6V1X1 2/20 0.42
DPP7 Q9UHL4 1/20 0.42
FAP Q12884 1/20 0.42
DPP9 Q86TI2 1/20 0.42
MGLL Q99685 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6684984 0.87 CACNA2D1 (0.52) HRH3CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL6657235 0.83 HRH3 (0.44) HRH3CACNA2D1CACNA1BCACNB1CACNA1C
Hydrochloric Acid SCHEMBL7512052 0.77 CACNA2D1 (0.53) HRH3CACNA2D1CACNA1BCACNB1CACNA1C
Hydrochloric Acid SCHEMBL6662221 0.76 HRH3 (0.62) HRH3PARP1KMT2AMEN1KDM4E
Hydrochloric Acid SCHEMBL6656943 0.74 HRH3 (0.58) HRH3PARP1KMT2AMEN1MAPT
SCHEMBL2250315 0.74 HRH3 (0.66) HRH3PARP1
SCHEMBL2250320 0.74 HRH3 (0.66) HRH3PARP1
SCHEMBL2250324 0.74 HRH3 (0.66) HRH3PARP1
SCHEMBL3909127 0.74 HRH3 (0.64) HRH3PARP1KMT2AMEN1OPRM1
SCHEMBL8083651 0.74 SLC6A2 (0.52) HRH3PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441728-A2 MODULATORS OF THE CHOLESTEROL BIOSYNTHETIC PATHWAY Vertex Pharmaceuticals Incorporated (US) 2004-08-04 EP disclosed
WO-2003037338-A2 MODULATORS OF THE CHOLESTEROL BIOSYNTHETIC PATHWAY VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-05-08 WO disclosed
EP-1257544-A2 PIPERAZINE AND PIPERIDINE DERIVATIVES FOR TREATMENT OR PREVENTION OF NEURONAL DAMAGE Vertex Pharmaceuticals Incorporated (US) 2002-11-20 EP disclosed
WO-2001058891-A2 PIPERAZINE AND PIPERIDINE DERIVATIVES FOR TREATMENT OR PREVENTION OF NEURONAL DAMAGE VERTEX PHARMACEUTICALS INCORPORATED (US) 2001-08-16 WO disclosed